logo

For the Inventor, By the Inventor

Lohmar, Germany

Teunis Schuurman

This inventor holds 17 USPTO granted patents, primarily in Dihydropyridine Compounds. Top assignees: Bayer Aktiengesellschaft, Troponwerke Gmbh & Co Kg, Troponwerke Gmbh & Co.. Active years: 1986-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teunis Schuurman. Retrieved from https://idiyas.com/inventor/teunis-schuurman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 94.1

Average Co-Inventor Count = 7.4

ph-index = 5

Forward Citations = 158(Granted Patents)


Location History:

  • Overath, DE (1986 - 1994)
  • Brummen, NL (1997)
  • Lohmar, DE (1992 - 2003)

Company Filing History:

goldMedal13 out of 12,268 
 
Bayer Aktiengesellschaft
 patents
silverMedal2 out of 32 
 
Troponwerke Gmbh & Co Kg
 patents
bronzeMedal2 out of 8 
 
Troponwerke Gmbh & Co.
 patents

Years Active: 1986-2003

Loading Chart...
Areas of Expertise:
Dihydropyridines
Phenyl-substituted
Aminomethyltetralins
Heterocyclic Analogues
Pyridoindole Derivatives
Piperazine Derivatives
Carboxylic Acid
Alkoxycarbonyl
17 patents (USPTO):Explore Patents
1. 6630494 - Phenyl-substituted 1,4-dihydropyridines (2003-10-07),
2. 6239155 - Phenyl-substituted 1,4-dihydropyridines (2001-05-29),
3. 6066655 - 4-phenyl-3-substituted 1,4-dihydropyridine esters (2000-05-23),
4. 6001857 - Heterocyclyl substituted dihydropyridines (1999-12-14),
5. 5731333 - 4-phenyl-3-substituted 1,4-dihydropyridine esters (1998-03-24),
6. 5665740 - Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, (1997-09-09),
7. 5658934 - Aryl-substituted alkoxycarbonyl-1,4-dihydropyridine-5-carboxylic acid (1997-08-19),
8. 5585392 - Substituted aminomethyltetralins and their heterocyclic analogues (1996-12-17),
9. 5506246 - Method for treating depression using substituted aminomethyltetralins (1996-04-09),
10. 5502064 - 4-heterocyclyl-substituted dihydropyridines (1996-03-26),
11. 5403849 - 4-heterocyclophenyl-substituted dihydropyridines (1995-04-04),
12. 5314884 - 2-pyrimidinyl-1-piperazine derivatives processes for their preparation (1994-05-24),
13. 5300523 - Substituted aminomethyltetralins and their heterocyclic analogues (1994-04-05),
14. 5137901 - Substituted aminomethyltetralins and their heterocyclic analogues (1992-08-11),
15. 4937343 - 2-pyrimidinyl-1-piperazine derivatives (1990-06-26),

Title: The Innovative Journey of Teunis Schuurman

Introduction: Teunis Schuurman is a pioneering inventor based in Lohmar, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Teunis Schuurman holds several patents in the areas of renewable energy, sustainable technologies, and advanced manufacturing processes, showcasing his commitment to creating a more efficient and eco-friendly world.

Career Highlights: With a career spanning over two decades, Teunis Schuurman has worked tirelessly to develop cutting-edge solutions that address some of the most pressing challenges faced by industries today. His innovative spirit and dedication to excellence have earned him recognition as a leading figure in the world of inventions.

Collaborations: Throughout his career, Teunis Schuurman has collaborated with top research institutions, universities, and industry experts to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: Teunis Schuurman's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs. His impact on the world of technology is undeniable, and his legacy will undoubtedly shape the future of innovation for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…